IL‐23: One cytokine in control of autoimmunity

Andrew L. Croxford; Florian Mair; Burkhard Becher

doi:10.1002/eji.201242598

journal article Sep 01, 2012

IL‐23: One cytokine in control of autoimmunity

Andrew L. Croxford Florian Mair Burkhard Becher

European Journal of Immunology Vol. 42 No. 9 pp. 2263-2273 · Wiley

View at Publisher Save 10.1002/eji.201242598

Abstract

During the past decade, it has been firmly established that IL‐23 is essential for disease development in several models of autoimmune disease, including psoriatic skin inflammation, inflammatory bowel disease (IBD), and experimental autoimmune encephalomyelitis (EAE). The mechanism by which IL‐23 exerts its pathogenic role has been mostly scrutinized in the context of Th17 cells, which were thought to mediate autoimmunity by secretion of IL‐17 family cytokines. However, the picture emerging now is one of multiple IL‐23‐responsive cell types, pro‐inflammatory cytokine induction, and pathogenic “licensing” following an IL‐23‐dominated interaction between the T cell and the antigen‐presenting cell (APC). This review will focus on our changing view of IL‐23‐dependent autoimmune pathologies with a particular emphasis on the responder cells and their IL‐23‐induced factors that ultimately mediate tissue destruction.

Topics

No keywords indexed for this article. Browse by subject →

References

109

[1]

10.1056/nejm199707173370301

[2]

10.1172/jci31720

[3]

10.4049/jimmunol.136.7.2348

[4]

Plasticity of CD4+ T Cell Lineage Differentiation

Liang Zhou, Mark M.W. Chong, Dan R. Littman

Immunity 10.1016/j.immuni.2009.05.001

[5]

10.1126/science.1068883

[6]

10.1038/41131

[7]

10.1038/nri2527

[8]

10.1126/science.1071059

[9]

10.1038/nature01991

[10]

10.1111/j.0105-2896.2005.00295.x

[11]

10.1073/pnas.87.17.6808

[12]

10.1016/s1074-7613(00)00070-4

[13]

Macatonia S. E. "Dendritic cells produce IL‐12 and direct the development of Th1 cells from naive CD4+ T cells" J. Immunol. (1995) 10.4049/jimmunol.154.10.5071

[14]

10.1038/ni794

[15]

10.1146/annurev.immunol.16.1.495

[16]

10.1016/0923-2494(96)83017-3

[17]

10.1126/science.8097338

[18]

10.1084/jem.185.5.817

[19]

10.1002/(sici)1521-4141(200004)30:4<1113::aid-immu1113>3.0.co;2-p

[20]

10.4049/jimmunol.164.1.100

[21]

Yoshimoto T. "IL‐12 up‐regulates IL‐18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL‐18 for IFN‐gamma production" J. Immunol. (1998) 10.4049/jimmunol.161.7.3400

[22]

10.1038/ni1377

[23]

10.1084/jem.181.1.381

[24]

10.1172/jci0215751

[25]

10.1038/nature01355

[26]

10.1084/jem.20041257

[27]

10.1016/j.smim.2007.10.011

[28]

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

Christi Parham, Madaline Chirica, Jacqueline Timans et al.

The Journal of Immunology 10.4049/jimmunol.168.11.5699

[29]

10.4049/jimmunol.171.9.4485

[30]

10.4049/jimmunol.170.4.2153

[31]

10.1002/eji.200939305

[32]

10.4049/jimmunol.0900732

[33]

10.1038/nature05969

[34]

10.1038/ni1488

[35]

10.1073/pnas.0809077106

[36]

10.1074/jbc.m705100200

[37]

10.1002/eji.200838511

[38]

10.1038/ni1391

[39]

Ghoreschi K. "T helper 17 cell heterogeneity and pathogenicity in autoimmune disease" Trends Immunol. 10.1016/j.it.2011.06.007

[40]

Sawcer S. "Genetic risk and a primary role for cell‐mediated immune mechanisms in multiple sclerosis" Nature

[41]

Luo J. "Structural basis for the dual recognition of IL‐12 and IL‐23 by ustekinumab" J. Mol. Biol. 10.1016/j.jmb.2010.07.046

[42]

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Craig L Leonardi, Alexa B Kimball, Kim A Papp et al.

The Lancet 10.1016/s0140-6736(08)60725-4

[43]

10.1016/s0140-6736(08)60726-6

[44]

10.1056/nejmoa0810652

[45]

10.1016/s1474-4422(08)70173-x

[46]

IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis

Burkhard Becher, Brigit G. Durell, Randolph J. Noelle

Journal of Clinical Investigation 10.1172/jci200319079

[47]

CONTRIBUTION OF INTERLEUKIN 17 TO SYNOVIUM MATRIX DESTRUCTION IN RHEUMATOID ARTHRITIS

Martine Chabaud, Patrick Garnero, Jean-Michel Dayer et al.

Cytokine 10.1006/cyto.2000.0681

[48]

A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

Richard H. Duerr, Kent D. Taylor, Steven R. Brant et al.

Science 10.1126/science.1135245

[49]

10.1136/gut.52.1.65

[50]

10.1038/nm1651

Showing 50 of 109 references

Metrics

158

Citations

109

References

Details

Published: Sep 01, 2012
Vol/Issue: 42(9)
Pages: 2263-2273
License: View

Authors

A

Andrew L. Croxford

Institute of Experimental Immunology University of Zurich Zurich Switzerland

F

Florian Mair

Institute of Experimental Immunology University of Zurich Zurich Switzerland

B

Burkhard Becher

Institute of Experimental Immunology University of Zurich Zurich Switzerland

Cite This Article

Andrew L. Croxford, Florian Mair, Burkhard Becher (2012). IL‐23: One cytokine in control of autoimmunity. European Journal of Immunology, 42(9), 2263-2273. https://doi.org/10.1002/eji.201242598

IL‐23: One cytokine in control of autoimmunity

You May Also Like